In 2018, the global distribution of new HIV infections in 2018 crossed a threshold: the majority of global new infections were among key populations and their sexual partners. This change is a result of the strong progress in settings with high HIV prevalence in eastern and southern Africa, combi
People who inject drugs
News
November 19, 2019
Resource
January 15, 2019
MEASURE Evaluation’s PLACE method builds local capacity to find HIV-positive people who are not on treatment, who may not know their HIV status, and who therefore are at risk of infecting others.
Event
January 14, 2019
Please join us for the next installment in the Key Populations: Evidence in Action webinar series
Resource
January 8, 2019
Despite progress in many aspects of the global HIV response, women - particularly adolescent girls and young women - continue to be disproportionately affected by HIV.
Blog
October 29, 2018
Of no surprise to those in the HIV field, the epidemic continues to be fueled by stigma, none more evident than among key and mobile populations, such as people who inject drugs and sex workers. Speakers at the Southern African HIV Clinicians Society conference shared their experiences in working with these groups and challenged participants to view them as people – and not merely a public health problem.
Blog
July 25, 2018
The USAID– and PEPFAR-supported LINKAGES project is excited to announce the arrival of a new supplement in the Journal of the International AIDS Society (JIAS) titled Optimizing the Impact of Key Population Programming Across the HIV Cascade.
Resource
July 24, 2018
Blog
July 23, 2018
Differentiated service delivery (DSD) has increasingly become the norm for HIV service providers and their clients; and not a moment too soon.
Resource
July 23, 2018
This Framework draws purposeful attention to men who have sex with men, transgender people, people who inject drugs and sex workers.
Resource
June 21, 2018
The LINKAGES project quarterly research digest comprises article abstracts from the peer-reviewed literature related to HIV and key populations in Africa, Asia and Pacific, Eastern Europe, Latin America, the Caribbean, and the Middle East.
